Verified Nov 2026
Other
·

Toronto, Ontario
·
Since 1974
Apotex Inc. is a privately held Canadian pharmaceutical manufacturer headquartered in Toronto, Ontario, founded in 1974. The company employs 5,000–10,000 people and generates an estimated $1–5B in annual revenue. It manufactures generic drugs, biosimilars, active pharmaceutical ingredients, and consumer health products across more than 45 countries, serving cardiovascular, CNS, oncology, and other therapeutic areas. In 2026, Apotex completed a strategic transaction with Cumberland Pharmaceuticals and established a sterile filling partnership with Halo Pharmaceuticals.
Apotex Inc. at a glance
Revenue
$1-5B
Est. band
Employees
5,000-10,000
Founded
1974
Headquarters
Toronto, Ontario
Import activity
2051
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Consumer Goods
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
2051
Named foreign suppliers
50
Top origins
India · China · Oman · Sri Lanka

Shared foreign counterparties do not establish that these companies buy from Apotex Inc..
What this tells a buyer
Apotex recorded 2,051 inbound shipments across documented customs entries, with volume sourced from India (Gland Pharma at 4,819 shipments) and China (Shandong Qilu Medicines at 1,032 shipments), along with materials from nine other countries.
The company manufactures approximately 25 billion doses annually and operates three divisions: Apotex Inc. for generics, Apobiologix for biosimilars, and Apotex Consumer Products for branded and natural health offerings, spanning over 1,000 products.
Founded by Dr. Barry Sherman, Apotex remains privately owned and ranks among pharmaceutical manufacturers by output and geographic reach.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
52 years in operation (founded 1974).
2,051 US import shipments on record.
Overview
Apotex Inc. is a privately held Canadian pharmaceutical manufacturer headquartered in Toronto, Ontario, founded in 1974. The company employs 5,000–10,000 people and generates an estimated $1–5B in annual revenue. It manufactures generic drugs, biosimilars, active pharmaceutical ingredients, and consumer health products across more than 45 countries, serving cardiovascular, CNS, oncology, and other therapeutic areas. In 2026, Apotex completed a strategic transaction with Cumberland Pharmaceuticals and established a sterile filling partnership with Halo Pharmaceuticals.
At a glance
Attribute | Detail |
|---|---|
Founded | 1974 |
Headquarters | Toronto, Ontario |
Employees | 5,000-10,000 |
Revenue | $1-5B (estimated) |
What Apotex Inc. makes
The company manufactures approximately 25 billion doses annually and operates three divisions: Apotex Inc. for generics, Apobiologix for biosimilars, and Apotex Consumer Products for branded and natural health offerings, spanning over 1,000 products.
Products and capabilities described on the company's own site include Suspension (source: apotex.com).
Trade and customs footprint
Apotex recorded 2,051 inbound shipments across documented customs entries, with volume sourced from India (Gland Pharma at 4,819 shipments) and China (Shandong Qilu Medicines at 1,032 shipments), along with materials from nine other countries. US customs bill-of-lading records list 2051 inbound shipments across 50 foreign suppliers, with top origins including India · China · Oman · Sri Lanka.
Latest developments
2026-11-12 — Apotex Delivers Strong Second Quarter 2027 Results and ... (apotex.com)
2026-10-01 — Sam Chun Dang Pharm. Expands Apotex Deal from a Single Product to a Portfolio, Adding New Macular Degeneration Treatment - First-Class Business Newspaper Financial News (fnnews.com)
2026-07-01 — Apotex completes previously announced strategic transaction with Cumberland Pharmaceuticals (apotex.com)
2026-04-14 — Apotex Announces Strategic U.S. Sterile Filling Partnership with Halo Pharmaceuticals (apotex.com)
2026-02-05 — Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal (apotex.com)
2025-05-07 — Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain following ocular surgery (apotex.com)
Company details
Founded by Dr. Barry Sherman, Apotex remains privately owned and ranks among pharmaceutical manufacturers by output and geographic reach. Apotex Inc. was founded in 1974, has an estimated 5,000-10,000 employees, and is headquartered in Toronto, Ontario. On the LightSource stability read it is rated "Established & active": 52 years in operation (founded 1974). 2,051 US import shipments on record.
Frequently asked questions
What does Apotex Inc. do?
Apotex Inc. is a privately held Canadian pharmaceutical manufacturer headquartered in Toronto, Ontario, founded in 1974. The company employs 5,000–10,000 people and generates an estimated $1–5B in annual revenue. It manufactures generic drugs, biosimilars, active pharmaceutical ingredients, and consumer health products across more than 45 countries, serving cardiovascular, CNS, oncology, and other therapeutic areas. In 2026, Apotex completed a strategic transaction with Cumberland Pharmaceuticals and established a sterile filling partnership with Halo Pharmaceuticals.
Where is Apotex Inc. headquartered?
Apotex Inc. is headquartered in Toronto, Ontario (150 Signet Drive, Toronto, Ontario, M9L 1T9).
When was Apotex Inc. founded?
Apotex Inc. was founded in 1974.
How big is Apotex Inc.?
Apotex Inc. has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).
Does Apotex Inc. import from overseas suppliers?
US customs bill-of-lading records show 2051 inbound shipments for Apotex Inc., with top origins including India · China · Oman · Sri Lanka.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
